David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
NVIDIA
NVDA
|
+$1.02B |
| 3 |
T-Mobile US
TMUS
|
+$911M |
| 4 |
Netflix
NFLX
|
+$699M |
| 5 |
Micron Technology
MU
|
+$672M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$768M |
| 2 |
Robinhood
HOOD
|
+$643M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$534M |
| 4 |
Microsoft
MSFT
|
+$493M |
| 5 |
Intuit
INTU
|
+$472M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.33% |
| 2 | Healthcare | 8.66% |
| 3 | Consumer Discretionary | 8.33% |
| 4 | Financials | 6.44% |
| 5 | Industrials | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Travel + Leisure Co
TNL
$4.51B
| $2.96M | ﹤0.01% |
57,294
-19,157
| -25% | -$900K |
|
2327
Reinsurance Group of America
RGA
$16.1B
| $2.95M | ﹤0.01% |
+14,896
| New | +$2.91M |
|
2328
PUT
Jefferies Financial Group
JEF
$12.2B
| $2.95M | ﹤0.01% |
54,000
+25,800
| +91% | +$1.28M |
|
2329
CALL
D.R. Horton
DHI
$41.7B
| $2.95M | ﹤0.01% |
22,900
-28,800
| -56% | -$3.55M |
|
2330
PUT
Charter Communications
CHTR
$18.4B
| $2.94M | ﹤0.01% |
7,200
| – | – |
|
|
DOO
2331
Bombardier Recreational Products
DOO
$4.42B
| $2.94M | ﹤0.01% |
60,496
+39,145
| +183% | +$1.54M |
|
2332
Flowers Foods
FLO
$1.52B
| $2.93M | ﹤0.01% |
183,605
-156,785
| -46% | -$2.7M |
|
|
CYBR
2333
CALL
DELISTED
CyberArk
CYBR
| $2.93M | ﹤0.01% |
7,200
+4,000
| +125% | +$1.46M |
|
2334
CALL
Penumbra
PEN
$12.7B
| $2.93M | ﹤0.01% |
11,400
| – | – |
|
|
CIVI
2335
PUT
DELISTED
Civitas Resources
CIVI
| $2.93M | ﹤0.01% |
106,300
-31,300
| -23% | -$906K |
|
2336
Summit Therapeutics
SMMT
$11.4B
| $2.92M | ﹤0.01% |
137,445
+107,666
| +362% | +$2.46M |
|
2337
Acco Brands
ACCO
$387M
| $2.91M | ﹤0.01% |
813,268
+134,889
| +20% | +$499K |
|
2338
Qualys
QLYS
$6.11B
| $2.91M | ﹤0.01% |
20,354
-58,820
| -74% | -$7.79M |
|
2339
Graham Holdings Company
GHC
$4.93B
| $2.9M | ﹤0.01% |
3,069
+1,582
| +106% | +$1.49M |
|
|
VTLE
2340
PUT
DELISTED
Vital Energy
VTLE
| $2.9M | ﹤0.01% |
180,100
-9,100
| -5% | -$149K |
|
2341
UWM Holdings
UWMC
$2.34B
| $2.9M | ﹤0.01% |
+699,504
| New | +$3.07M |
|
2342
Aurinia Pharmaceuticals
AUPH
$2.2B
| $2.89M | ﹤0.01% |
341,540
+77,117
| +29% | +$618K |
|
|
LPRO
2343
DELISTED
Open Lending Corp
LPRO
| $2.89M | ﹤0.01% |
1,487,638
+1,440,369
| +3,047% | +$2.33M |
|
2344
CALL
Antero Resources
AR
$11.8B
| $2.88M | ﹤0.01% |
71,500
+65,100
| +1,017% | +$2.47M |
|
|
BNY
2345
CALL
Bank of New York Mellon
BNY
$111B
| $2.88M | ﹤0.01% |
31,600
-96,700
| -75% | -$8.21M |
|
|
PPTA
2346
Perpetua Resources
PPTA
$3.22B
| $2.88M | ﹤0.01% |
+237,079
| New | +$3.19M |
|
2347
iShares S&P 500 Growth ETF
IVW
$76B
| $2.88M | ﹤0.01% |
26,117
+9,542
| +58% | +$944K |
|
|
AKRO
2348
DELISTED
Akero Therapeutics
AKRO
| $2.87M | ﹤0.01% |
53,866
+41,707
| +343% | +$1.9M |
|
|
PR
2349
CALL
Permian Resources
PR
$19.1B
| $2.87M | ﹤0.01% |
+210,800
| New | +$2.71M |
|
2350
PUT
Costco
COST
$424B
| $2.87M | ﹤0.01% |
2,900
-7,100
| -71% | -$7.06M |
|
Similar funds
David Shaw's Q2 2025 Portfolio in Review
As of Q2 2025, David Shaw held 4,838 positions worth $141B, up 26% from $112B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q2 2025 filing shows 647 new, 1,556 increased, 1,611 reduced and 532 closed positions. Its largest new stake was Sea Limited: 1,365,221 shares worth $218M. The largest sale was GE Vernova, an estimated $768M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q2 2025 buy was Sea Limited: 1,365,221 shares worth $218M.
- David Shaw added most to Apple in Q2 2025, an estimated $1.2B increase.
- David Shaw's biggest Q2 2025 reduction was GE Vernova, cutting an estimated $768M.
- David Shaw fully exited Novo Nordisk in Q2 2025, selling an estimated $176M.
- David Shaw's ten largest holdings make up 12% of its $141B portfolio in Q2 2025.
- David Shaw opened 647 new positions and closed 532 in Q2 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $141B.
Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.